Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 31 for “"S1pr"”.
-
Nachweis von Autoantikörpern gegen Sphingosin-1-Phosphat-Rezeptoren bei Systemischer Sklerose und Pulmonal-Arterieller-Hypertonie
… S1P-Rezeptoren des kardiovaskulären Systems (S1PR1–3) potenzielle Ziele für aAb darstellen und sich bei SSc und SSc-PAH höhere Prävalenzen nachweisen lassen. METHODEN: In vitro Assays für die Detektion von S1PR-aAb wurden konzipiert. Hierfür wurden Fusionsproteine aus S1PR und Luciferase …
-
Utilidad de la determinación de esfingosina-1-fostato y su receptor como factor pronóstico y de manejo terapeútico en pacientes con artritis psoriásica
… esquelético y el esfingolípido S1P y su receptor S1PR participan en esta interacción. Es probable que la señalización de S1P-S1PR1 participe en el mantenimiento del recambio óseo continuo en condiciones fisiológicas, mientras conduce a la patogénesis formación y erosión ósea durante la …
-
Sphingosine-1-Phosphate and Fingolimod (FTY720) Regulate ICl,swell In HL-1 Cardiac Myocytes via Intracellular Binding And Mitochondrial ROS Production
… primarily act via G-protein coupled receptors (S1PR; S1PR1-3 in heart), but several intracellular S1P ligands are known. We investigated how these agents regulate ICl,swell. ICl,swell was elicited by bath S1P (500 nM), FTY720 (S1PR1,3 agonist; 10 μM), and SEW2871 (S1PR1 agonist; 10 μM) and was …
-
Investigating the molecular mechanisms of CD4 T cell persistence at inflamed peripheral tissues
… at inflamed tissues, Th1 cells were treated with S1PR agonists or antagonists, prior to transfer. Fewer Th1 cells were recovered from the inflammatory site of mice injected with antagonist treated cells. Additionally, S1PR agonism was sufficient to induce Th1 cell persistence at non-inflamed …
-
Antitumor effect of the combination of exogenous sphingosine-1-phosphate(S1P), S1P receptor 1(S1PR1) antibody and carboplatin against human breast cancer cells
… mediator, can regulate S1P receptor (S1PR)-dependent or S1PR-independent cell proliferation, apoptosis, autophagy, migration, survival, angiogenesis, and differentiation. Previous studies from our laboratory have shown that S1P can selectively cause cell death in breast cancer cell …
-
Computer-Aided Elucidation of Structural Determinants for Sphingosine-1-phosphate Receptor Subtype Selectivity and Class A GPCR Activation
… campaigns. Sphingosine-1-phosphate receptors (S1PR) has shown to be effective drug targets against multiple sclerosis (MS), but non-selective drugs suffer from serious adverse effects. Furthermore, targeting a single S1PR holds a lot of potentials to modulate different inflammatory and …
-
Characterizing Effects of Sphingosine-1-Phosphate Receptor 1 Activation in Subtypes of Central Amygdala Neurons and Effects of Prenatal Methadone Exposure on Motor Cortex Neurons in Mice
… immune response and inflammation. S1P receptor (S1PR) ligands have been utilized as an effective immunosuppressant, treatment in multiple sclerosis and studied as a treatment for pain. The primary cellular response to S1P is thought to be elicited through S1PR type 1 (S1PR1). My first goal was to …
-
Modulation of Sphingosine-1-Phosphate Receptor Signaling as a Regenerative Immunotherapy for Volumetric Muscle Loss
… through its 5 G protein-coupled receptors (S1PR1-5) to elicit a range of cellular responses governing complex functions such as immune cell trafficking, vascular integrity, and fibrosis. Using a pre-clinical model of VML, we found that critically sized injuries are characterized by a marked …
-
Evaluation der SARS-CoV-2 spezifischen T Zell Response mittels FACS basierten Assay bei Multiple Sklerose Patienten unter immunmodulatorischer Therapie
… (Ocrelizumab) und Sphingosin-1-Phosphatrezeptor (S1PR)-Modulation (Fingolimod), die sowohl miteinander als auch mit einer Kontrollgruppe, bestehend aus PwMS ohne Medikation, sowie PwMS unter Therapie mit Alemtuzumab und Natalizumab verglichen wurde. Die Erfassung der SARS-CoV-2 spezifischen T und …
-
Biological Clocks, Inflammation, and Multiorgan Damage In Sickle Cell Disease
… sickling. S1P signals via five S1P receptors (S1PR) regulates several pathophysiological functions. In the first chapter of this dissertation, I explored the role of S1PRs in SCD by utilizing pharmacologic and genetic tools. To determine the role of S1P-S1PRs signaling in SCD, I treated …
-
Sphingolipids as modulators of T cell function
… modulating T cell biology. We propose the S1P/S1PR1/5 signaling axis as the potential survival pathway for Smpdl3b+ memory CD8+ T cells and UTCs, mainly in lymph nodes. Possibly, Smpdl3b regulates S1P/S1PR signaling by balancing ligandreceptor endocytosis, while UTCs migrate to lymph nodes …
-
Pathogenetic mechanisms and therapeutic target discovery in chronic immune-mediated inflammatory diseases: insights into the role of the lymphatic system and drug repurposing strategies
… that sphingosine-1-phosphate receptor (S1PR) modulators, such as etrasimod, profoundly alter T-cell migration, highlighting lymphocyte trafficking as a tractable therapeutic axis in IBD. In the second part, we applied transcriptome-guided drug repurposing pipelines to identify novel …
-
Overcoming immune responses to retinal gene therapy
… fingolimod, a sphingosine-1-phosphate receptor (S1PR) modulator, as the most effective steroid-sparing approach for GTAU amelioration.<br/>A short-term 25-day fingolimod regimen produced sustained suppression extending beyond treatment withdrawal, demonstrating efficacy equivalent to high-dose …
-
The critical role of memory CD4+ T cells in the inaugural generation of IgE
… across multiple tissue sites independent of S1PR-mediated cell migration, suggesting the potency of memory CD4+ T cells in maintaining allergic memory. Altogether, our findings suggest that these plastic memory CD4+ T cells are capable of independently perpetuating allergic disease. Our work …
-
INVESTIGATING THE MOLECULAR MECHANISMS OF ATHEROSCLEROSIS DEVELOPMENT IN THE MOUSE: EMPHASIS ON THE MACROPHAGE SPHINGOSINE-1-PHOSPHATE RECEPTOR 1
… In this thesis, the role of S1P receptors (S1PRs) in atherosclerosis is explored, with emphasis in macrophage apoptosis. In particular, the importance of the macrophage S1PR1 and its role in apoptosis and atherosclerosis was evaluated. We demonstrated that diabetes exacerbates …
-
The Role of Sphingosine-1-Phosphate in the Reverse Transendothelial Migration of Aortic Resident Intimal Myeloid Cells
… (S1P) signaling via S1P receptors (S1PRs) is required for immune cell trafficking in lymphoid tissues, we hypothesize that S1P signaling is also required for RTM of intimal MCs following systemic stimulation of TLRs. In wildtype C57BL/6 mice, LPS induced the intimal expression of …
-
Sphingosine 1-phosphate enhances excitability of sensory neurons through sphingosine 1-phosphate receptors 1 and/or 3
… S1P acts through a family of five S1P receptors, S1PR1-5, all of which are G protein-coupled receptors associated with different G proteins. Previous work from our laboratory shows that externally applied S1P increases the excitability of small-diameter sensory neurons by enhancing the action …
-
Investigating the role of dual sphingosine 1-phosphate receptor signalling in neuroprotection
… through five G-protein coupled receptors (S1PR1-5). S1P synthesis occurs through the phosphorylation of sphingosine by sphingosine kinase 1 (SphK1) or SphK2. S1P levels and SphK activity are reduced in multiple neurodegenerative paradigms including Alzheimer’s disease (AD). Pharmacological …
-
ANXIOLYTIC INTERVENTION: MODULATION OF CELL TYPES DUE TO NICOTINE WITHDRAWAL
… acts on sphingosine-1-phosphate receptors (S1PRs) on astrocytes, which were evaluated in both naïve (nicotine free) and nicotine withdrawal mice. Naïve and withdrawal cohorts exhibited variability across S1PR subtypes and routes of administration. Behavioral testing assessing anxiety-like …
-
Untersuchung der natürlichen Killerzellen (NK-Zellen) unter Fingolimod-Behandlung
… funktioneller Sphingosin-1-Phosphat-Rezeptor (S1PR) Antagonist, ist seit 2011 in der Europäischen Union ein zugelassenes Medikament zur Behandlung der Multiple Sklerose (MS). Es bewirkt das Zurückhalten von S1PR1-exprimierenden Immunzellen im Lymphknoten (LK). U.a. wird der S1PR1-Rezeptor von …
Page 1 of 2